AbbVie Inc.

AbbVie Inc. is a globally recognized biopharmaceutical company dedicated to the discovery, development, and distribution of a range of innovative medicines. Serving key industries including immunology, oncology, virology, and neurology, AbbVie aims to address some of the most complex and critical health challenges. Established in 2013 following its spin-off from Abbott Laboratories, AbbVie has focused on harnessing advanced scientific research and expertise to create life-changing treatments. Its portfolio includes renowned products like the rheumatoid arthritis drug Humira and the cancer treatment Imbruvica. AbbVie operates an extensive pipeline of therapies, continuously investing in new drug development to maintain competitive positioning and enhance patient care outcomes. As a pivotal player in the biopharmaceutical sector, AbbVie collaborates with healthcare providers, government entities, and academic institutions globally, amplifying its reach and impact on public health. With headquarters in North Chicago, Illinois, AbbVie sustains a significant presence in the global healthcare market, demonstrating a commitment to scientific innovation and therapeutic advancement.